May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Orthovanadate Alters The Cytoskeleton Of Trabecular Meshwork Cells And Increases Outflow Facility In Live Monkeys
Author Affiliations & Notes
  • C.J. Tan
    Ophthalmology & Visual Sciences, University of Wisconsin, Madison, WI
  • J.A. Kiland
    Ophthalmology & Visual Sciences, University of Wisconsin, Madison, WI
  • B.T. Gabelt
    Ophthalmology & Visual Sciences, University of Wisconsin, Madison, WI
  • P.L. Kaufman
    Ophthalmology & Visual Sciences, University of Wisconsin, Madison, WI
  • Footnotes
    Commercial Relationships  C.J. Tan, None; J.A. Kiland, None; B.T. Gabelt, None; P.L. Kaufman, None.
  • Footnotes
    Support  NIH EY02698, RPB, OPREF
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1858. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.J. Tan, J.A. Kiland, B.T. Gabelt, P.L. Kaufman; Orthovanadate Alters The Cytoskeleton Of Trabecular Meshwork Cells And Increases Outflow Facility In Live Monkeys . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1858.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Vanadate compounds inhibit protein–phosphotyrosine phosphatases (PPTPase) which help regulate the actin cytoskeleton and cell adhesions. Vanadate is reported to reduce intraocular pressure (IOP) by affecting aqueous secretion, but whether it affects outflow facility (OF) is unclear.

Methods: : The effect of sodium orthovanadate (Na3VO4) on OF and IOP was studied in live cynomolgus monkeys. Total OF was measured by 2–level constant pressure perfusion of the anterior chamber (AC) before and for 1.5 hours after exchange with 1mM Na3VO4, or vehicle, followed by continuous AC infusion of corresponding drug/vehicle solution in opposite eyes. Topical 1% Na3VO4 (55mM) was given daily (4x25microL drops) for 4 days. Goldmann IOP measured over 6 hours on days 1 and 4 was compared between treatment and control groups, with analysis expressed as the mean±s.e.m. and range of differences of IOP over the entire 6–hour measurement periods. The effect of Na3VO4 on cultured trabecular meshwork (TM) cells was examined by immunofluorescence microscopy.

Results: : Na3VO4 increased OF by 29.3±8.8% (mean±s.e.m) over the 1.5–hour perfusion interval when adjusted for baseline and contralateral eye washout (p=0.01; n=12). On day 1, baseline IOP in pre–treated eyes was 16.2±1.5mmHg and in control eyes was 15.9±1.3mmHg. Following treatment on day 1, IOP was no different between treated eyes (16.6±0.2mmHg) and control eyes (17.4±0.3mmHg). On day 4, IOP was lower in treated eyes (13.5±0.8mmHg) than control eyes (16.1±0.2mmHg; p=0.009; range of differences: 2.0–5.3mmHg). IOP in the same treated eyes was lower on day 4 than on day 1 (p=0.0000; range of reduction: 3.0–6.5mmHg). In vitro, 1mM Na3VO4 disrupted the actin cytoskeleton and cells separated within 2 hours. Vinculin staining at focal adhesions was reduced. Cells reformed confluent monolayers within 24 hours of replacing Na3VO4–containing medium with control medium.

Conclusions: : Na3VO4 increases OF at least modestly and reduces IOP in monkeys. Increased OF appears to be mediated by PPTPase inhibition which reversibly alters the actin cytoskeleton and cell adhesions of TM cells.

Keywords: cytoskeleton • outflow: trabecular meshwork • trabecular meshwork 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×